Marcus Jonathan L 4
4 · CME GROUP INC. · Filed Mar 17, 2026
Research Summary
AI-generated summary of this filing
CME Group GC Jonathan L. Marcus Receives 5,270-Share Award
What Happened
Jonathan L. Marcus, Senior Managing Director & General Counsel of CME Group, was awarded 5,270 performance shares on 2026-03-15 at an indicated value of $311.40 per share (total ~$1,641,078). To satisfy tax withholding, he surrendered a total of 2,638 shares (2,377 + 261), leaving a net 2,632 shares retained from the award (net value ≈ $819,605). These transactions are recorded as an award (code A) and share surrenders for tax withholding (code F).
Key Details
- Transaction date: 2026-03-15; Form 4 filed: 2026-03-17 (filed timely, within the usual two-business-day window).
- Award: 5,270 performance shares @ $311.40 each = $1,641,078 (code A).
- Tax withholding surrenders: 2,377 shares @ $311.40 = $740,198 and 261 shares @ $311.40 = $81,275 (total surrendered = 2,638 shares, $821,473; code F).
- Net shares retained from vesting: 2,632 shares (≈ $819,605).
- Shares owned after the transaction are not reported on this Form 4.
- Footnotes: F1 notes the shares are performance awards granted in 2022 under CME’s Omnibus Stock Plan, vesting based on total shareholder return vs. the S&P 500 for the 2023–2025 performance period. F2/F3 state the surrendered shares were to satisfy tax-withholding for the performance share award and for restricted stock vesting on 3/15/2026.
Context
This filing reflects the vesting of compensation (performance and restricted stock) and routine tax-withholding via share surrender — not an open-market sale or purchase. Such award vestings are common executive compensation events and do not by themselves indicate a buy/sell signal about the company.
Insider Transaction Report
- Award
Common Stock Class A
[F1]2026-03-15$311.40/sh+5,270$1,641,078→ 13,121 total - Tax Payment
Common Stock Class A
[F2]2026-03-15$311.40/sh−2,377$740,198→ 10,744 total - Tax Payment
Common Stock Class A
[F3]2026-03-15$311.40/sh−261$81,275→ 10,483 total
Footnotes (3)
- [F1]Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025.
- [F2]Mr. Marcus surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award.
- [F3]Mr. Marcus surrendered shares to the company to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2026.